Drug Profile
Anti-VCAM-1 monoclonal antibody
Alternative Names: Anti-VCAM-1Latest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Unknown
- Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants; Vascular cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Graft-versus-host disease; Transplant rejection
Most Recent Events
- 15 Apr 1997 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
- 10 Mar 1995 Preclinical development for Graft-versus-host disease in USA (Unknown route)
- 10 Mar 1995 Preclinical development for Transplant rejection in Japan (Unknown route)